158 related articles for article (PubMed ID: 20955617)
21. Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts.
Argani P; Shaukat A; Kaushal M; Wilentz RE; Su GH; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH
Cancer; 2001 Apr; 91(7):1332-41. PubMed ID: 11283934
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of extrahepatic bile duct resection for advanced gallbladder cancer.
Sakamoto Y; Kosuge T; Shimada K; Sano T; Hibi T; Yamamoto J; Takayama T; Makuuchi M
J Surg Oncol; 2006 Sep; 94(4):298-306. PubMed ID: 16917876
[TBL] [Abstract][Full Text] [Related]
23. Ras p21 protein immunoreactivity and its relationship to p53 expression and prognosis in gallbladder and extrahepatic biliary carcinoma.
Lee CS
Eur J Surg Oncol; 1997 Jun; 23(3):233-7. PubMed ID: 9236898
[TBL] [Abstract][Full Text] [Related]
24. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
25. ERCC1 mRNA expression as a postoperative prognostic marker in extrahepatic bile duct cancer.
Uemura S; Kuramochi H; Higuchi R; Nakajima G; Yamamoto M
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S627-33. PubMed ID: 24763983
[TBL] [Abstract][Full Text] [Related]
26. Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation.
Giatromanolaki A; Fountzilas G; Koukourakis MI; Arapandoni P; Theologi V; Kakolyris S; Georgoulias V; Harris AL; Gatter KC
Clin Exp Metastasis; 1998 Oct; 16(7):665-72. PubMed ID: 9932613
[TBL] [Abstract][Full Text] [Related]
27. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
[TBL] [Abstract][Full Text] [Related]
28. Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine.
Ko JC; Tsai MS; Kuo YH; Chiu YF; Weng SH; Su YC; Lin YW
Biochem Pharmacol; 2011 Mar; 81(5):680-90. PubMed ID: 21168393
[TBL] [Abstract][Full Text] [Related]
29. p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions.
Ajiki T; Onoyama H; Yamamoto M; Asaka K; Fujimori T; Maeda S; Saitoh Y
Hepatogastroenterology; 1996; 43(9):521-6. PubMed ID: 8799388
[TBL] [Abstract][Full Text] [Related]
30. Should the extrahepatic bile duct be resected or preserved in R0 radical surgery for advanced gallbladder carcinoma? Results of a Japanese Society of Biliary Surgery Survey: a multicenter study.
Araida T; Higuchi R; Hamano M; Kodera Y; Takeshita N; Ota T; Yoshikawa T; Yamamoto M; Takasaki K
Surg Today; 2009; 39(9):770-9. PubMed ID: 19779773
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Tumor Markers and Their Impact on Prognosis in Gallbladder, Bile Duct and Cholangiocellular Carcinomas - A Pilot Study.
Liska V; Treska V; Skalicky T; Fichtl J; Bruha J; Vycital O; Topolcan O; Palek R; Rosendorf J; Polivka J; Holubec L
Anticancer Res; 2017 Apr; 37(4):2003-2009. PubMed ID: 28373474
[TBL] [Abstract][Full Text] [Related]
32. Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma.
Hui AM; Cui X; Makuuchi M; Li X; Shi YZ; Takayama T
Hepatology; 1999 Nov; 30(5):1167-73. PubMed ID: 10534337
[TBL] [Abstract][Full Text] [Related]
33. Thymidine phosphorylase expression in gallbladder adenocarcinomas.
Giatromanolaki A; Sivridis E; Simopoulos C; Polychronidis A; Gatter KC; Harris AL; Koukourakis MI
Int J Surg Pathol; 2002 Jul; 10(3):181-8. PubMed ID: 12232571
[TBL] [Abstract][Full Text] [Related]
34. Interpretation of Pin-1 and VEGF-C expression in breast infiltrating duct carcinoma.
Kim BC; Han SI; Lim SC
Oncol Rep; 2009 Dec; 22(6):1381-90. PubMed ID: 19885590
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of Ki-67 and p53 antigen expression in carcinomas of bile duct and gallbladder.
Shrestha ML; Miyake H; Kikutsuji T; Tashiro S
J Med Invest; 1998 Aug; 45(1-4):95-102. PubMed ID: 9864969
[TBL] [Abstract][Full Text] [Related]
36. Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction.
Masuhara S; Kasuya K; Aoki T; Yoshimatsu A; Tsuchida A; Koyanagi Y
J Hepatobiliary Pancreat Surg; 2000; 7(2):198-205. PubMed ID: 10982614
[TBL] [Abstract][Full Text] [Related]
37. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
[TBL] [Abstract][Full Text] [Related]
38. p53 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater.
Lee CS; Pirdas A
Pathology; 1995 Apr; 27(2):117-20. PubMed ID: 7567135
[TBL] [Abstract][Full Text] [Related]
39. Survivin expression and its clinical significance in pancreatic cancer.
Lee MA; Park GS; Lee HJ; Jung JH; Kang JH; Hong YS; Lee KS; Kim DG; Kim SN
BMC Cancer; 2005 Oct; 5():127. PubMed ID: 16202147
[TBL] [Abstract][Full Text] [Related]
40. Gallbladder carcinoma with biliary invasion: clinical analysis of the differences from nonbiliary invasion.
Chan KM; Yeh TS; Yu MC; Jan YY; Hwang TL; Chen MF
World J Surg; 2005 Jan; 29(1):72-5. PubMed ID: 15599737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
